THIAZOLE DERIVATIVES AS CHEMOKINE RECEPTOR ANTAGONISTS
The use of a compound of formula (I) or a pharmaceutically acceptable salt or solvate thereof, wherein R , R, R , R , R and R are as defined in the specification, in the preparation of a medicament for the treatment of C-C chemokine mediated conditions. Novel compounds of formula (I) and pharmaceuti...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | BOWER, JUSTIN FAIRFIELD HAMLIN, GORDON ALEXANDER WINTER, JON |
| description | The use of a compound of formula (I) or a pharmaceutically acceptable salt or solvate thereof, wherein R , R, R , R , R and R are as defined in the specification, in the preparation of a medicament for the treatment of C-C chemokine mediated conditions. Novel compounds of formula (I) and pharmaceutical compositions containing them are also described and claimed.
L'invention concerne l'utilisation d'un composé représenté par la formule générale (I) ou d'un de ses sels ou solvates de qualité pharmaceutique, dans la préparation d'un médicament destiné au traitement de troubles induits par la chimiokine CC. Dans cette formule, R , R, R , R , R et R désignent des éléments définis dans la description de la présente demande. L'invention concerne également de nouveaux composés représentés par la formule générale (I) et des compositions pharmaceutiques contenant ces composés. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2005118579A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2005118579A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2005118579A23</originalsourceid><addsrcrecordid>eNrjZDAL8fB0jPL3cVVwcQ3yDHMM8QxzDVZwDFZw9nD19ff29HNVCHJ1dg0I8Q9ScPQLcXT39_MMDgnmYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXx4f5GBgamhoYWpuaWjkbGxKkCANiAKTc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>THIAZOLE DERIVATIVES AS CHEMOKINE RECEPTOR ANTAGONISTS</title><source>esp@cenet</source><creator>BOWER, JUSTIN FAIRFIELD ; HAMLIN, GORDON ALEXANDER ; WINTER, JON</creator><creatorcontrib>BOWER, JUSTIN FAIRFIELD ; HAMLIN, GORDON ALEXANDER ; WINTER, JON</creatorcontrib><description>The use of a compound of formula (I) or a pharmaceutically acceptable salt or solvate thereof, wherein R , R, R , R , R and R are as defined in the specification, in the preparation of a medicament for the treatment of C-C chemokine mediated conditions. Novel compounds of formula (I) and pharmaceutical compositions containing them are also described and claimed.
L'invention concerne l'utilisation d'un composé représenté par la formule générale (I) ou d'un de ses sels ou solvates de qualité pharmaceutique, dans la préparation d'un médicament destiné au traitement de troubles induits par la chimiokine CC. Dans cette formule, R , R, R , R , R et R désignent des éléments définis dans la description de la présente demande. L'invention concerne également de nouveaux composés représentés par la formule générale (I) et des compositions pharmaceutiques contenant ces composés.</description><edition>7</edition><language>eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2005</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20051215&DB=EPODOC&CC=WO&NR=2005118579A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20051215&DB=EPODOC&CC=WO&NR=2005118579A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BOWER, JUSTIN FAIRFIELD</creatorcontrib><creatorcontrib>HAMLIN, GORDON ALEXANDER</creatorcontrib><creatorcontrib>WINTER, JON</creatorcontrib><title>THIAZOLE DERIVATIVES AS CHEMOKINE RECEPTOR ANTAGONISTS</title><description>The use of a compound of formula (I) or a pharmaceutically acceptable salt or solvate thereof, wherein R , R, R , R , R and R are as defined in the specification, in the preparation of a medicament for the treatment of C-C chemokine mediated conditions. Novel compounds of formula (I) and pharmaceutical compositions containing them are also described and claimed.
L'invention concerne l'utilisation d'un composé représenté par la formule générale (I) ou d'un de ses sels ou solvates de qualité pharmaceutique, dans la préparation d'un médicament destiné au traitement de troubles induits par la chimiokine CC. Dans cette formule, R , R, R , R , R et R désignent des éléments définis dans la description de la présente demande. L'invention concerne également de nouveaux composés représentés par la formule générale (I) et des compositions pharmaceutiques contenant ces composés.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2005</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAL8fB0jPL3cVVwcQ3yDHMM8QxzDVZwDFZw9nD19ff29HNVCHJ1dg0I8Q9ScPQLcXT39_MMDgnmYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXx4f5GBgamhoYWpuaWjkbGxKkCANiAKTc</recordid><startdate>20051215</startdate><enddate>20051215</enddate><creator>BOWER, JUSTIN FAIRFIELD</creator><creator>HAMLIN, GORDON ALEXANDER</creator><creator>WINTER, JON</creator><scope>EVB</scope></search><sort><creationdate>20051215</creationdate><title>THIAZOLE DERIVATIVES AS CHEMOKINE RECEPTOR ANTAGONISTS</title><author>BOWER, JUSTIN FAIRFIELD ; HAMLIN, GORDON ALEXANDER ; WINTER, JON</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2005118579A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2005</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>BOWER, JUSTIN FAIRFIELD</creatorcontrib><creatorcontrib>HAMLIN, GORDON ALEXANDER</creatorcontrib><creatorcontrib>WINTER, JON</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BOWER, JUSTIN FAIRFIELD</au><au>HAMLIN, GORDON ALEXANDER</au><au>WINTER, JON</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>THIAZOLE DERIVATIVES AS CHEMOKINE RECEPTOR ANTAGONISTS</title><date>2005-12-15</date><risdate>2005</risdate><abstract>The use of a compound of formula (I) or a pharmaceutically acceptable salt or solvate thereof, wherein R , R, R , R , R and R are as defined in the specification, in the preparation of a medicament for the treatment of C-C chemokine mediated conditions. Novel compounds of formula (I) and pharmaceutical compositions containing them are also described and claimed.
L'invention concerne l'utilisation d'un composé représenté par la formule générale (I) ou d'un de ses sels ou solvates de qualité pharmaceutique, dans la préparation d'un médicament destiné au traitement de troubles induits par la chimiokine CC. Dans cette formule, R , R, R , R , R et R désignent des éléments définis dans la description de la présente demande. L'invention concerne également de nouveaux composés représentés par la formule générale (I) et des compositions pharmaceutiques contenant ces composés.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2005118579A2 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | THIAZOLE DERIVATIVES AS CHEMOKINE RECEPTOR ANTAGONISTS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T03%3A41%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BOWER,%20JUSTIN%20FAIRFIELD&rft.date=2005-12-15&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2005118579A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |